[Skip to Content]
[Skip to Content Landing]
Clinical Notes
November 2, 1964

Hemodialysis in the Home

Author Affiliations

Boston

From the Cardiorenal Section of Peter Bent Brigham Hospital (E. Cameron and Drs. Merrill and Hampers); Harvard Medical School (Drs. Merrill, Schupak, and Hampers); Howard Hughes Medical Institute (Dr. Merrill); and the National Institutes of Health, Bethesda, Md (Dr. Hampers). Dr. Schupak is now at the Brooklyn-Cumberland Medical Center, Brooklyn, New York.

JAMA. 1964;190(5):468-470. doi:10.1001/jama.1964.03070180066018
Abstract

IN RECENT YEARS it has been adequately proven that for some patients with chronic renal failure in whom conservative treatment is inadequate, useful existence may be maintained for significant periods of time by the use of a regularly scheduled program of hemodialysis with the artificial kidney. Although the number of patients so treated is small, the preponderance of evidence indicates that in the hands of an experienced team hemodialysis may be considered a successful, though temporary, means of treating chronic uremia.1 The demonstration of this possibility raises important questions about the need for its wider application.

It is estimated that in the US, 2,000 patients per year who die of chronic renal failure might survive with this form of treatment.2 The cost of maintaining eight patients in this fashion has been estimated at $10,000 per patient per year2 by the chronic dialysis center in Seattle. This figure

First Page Preview View Large
First page PDF preview
First page PDF preview
×